Literature DB >> 7489498

Mammalian splicing factor SF3a120 represents a new member of the SURP family of proteins and is homologous to the essential splicing factor PRP21p of Saccharomyces cerevisiae.

A Krämer1, F Mulhauser, C Wersig, K Gröning, G Bilbe.   

Abstract

Mammalian splicing factor SF3a consists of three subunits of 60, 66, and 120 kDa and functions early during pre-mRNA splicing by converting the U2 snRNP into its active form. A cDNA encoding the 120-kDa subunit of SF3a has been cloned. The SF3a120 gene was localized to human chromosome 22, and three mRNAs of 3.2, 3.8, and 5.7 kb are ubiquitously expressed. The N-terminal half of the deduced SF3a120 amino acid sequence contains a tandemly repeated motif (the SURP module) that has recently been identified in the essential splicing factor PRP21p of Saccharomyces cerevisiae, the Drosophila alternative splicing regulator suppressor-of-white-apricot, and four proteins from nematodes and mammals; the C-terminal half is organized into a proline-rich region and a ubiquitin-like domain. The spacing between the SURP modules and the protein's essential function in constitutive splicing identify SF3a120 as the mammalian homologue of yeast PRP21p. Binding studies with truncated derivatives of SF3a120 revealed that the SURP domains function in binding to SF3a60, whereas a region of 130 amino acids C-terminal to these domains is essential for contacts with SF3a66.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489498      PMCID: PMC1369079     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  33 in total

1.  Domains in human splicing factors SF3a60 and SF3a66 required for binding to SF3a120, assembly of the 17S U2 snRNP, and prespliceosome formation.

Authors:  D Nesic; A Krämer
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes.

Authors:  O V Makarova; E M Makarov; R Lührmann
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Authors:  M Gunther; M Laithier; O Brison
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

4.  Structure and assembly of the SF3a splicing factor complex of U2 snRNP.

Authors:  Pei-Chun Lin; Rui-Ming Xu
Journal:  EMBO J       Date:  2012-02-07       Impact factor: 11.598

5.  Ubiquitin binding by a variant Jab1/MPN domain in the essential pre-mRNA splicing factor Prp8p.

Authors:  Priya Bellare; Alan K Kutach; Amy K Rines; Christine Guthrie; Erik J Sontheimer
Journal:  RNA       Date:  2006-02       Impact factor: 4.942

6.  A role for ubiquitin in the spliceosome assembly pathway.

Authors:  Priya Bellare; Eliza C Small; Xinhua Huang; James A Wohlschlegel; Jonathan P Staley; Erik J Sontheimer
Journal:  Nat Struct Mol Biol       Date:  2008-04-20       Impact factor: 15.369

7.  Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells.

Authors:  W Seghezzi; K Chua; F Shanahan; O Gozani; R Reed; E Lees
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  Interaction domains and nuclear targeting signals in subunits of the U2 small nuclear ribonucleoprotein particle-associated splicing factor SF3a.

Authors:  Ching-Jung Huang; Fabio Ferfoglia; Flore Raleff; Angela Krämer
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

9.  CUS2, a yeast homolog of human Tat-SF1, rescues function of misfolded U2 through an unusual RNA recognition motif.

Authors:  D Yan; R Perriman; H Igel; K J Howe; M Neville; M Ares
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  U2 snRNA-protein contacts in purified human 17S U2 snRNPs and in spliceosomal A and B complexes.

Authors:  Olexandr Dybkov; Cindy L Will; Jochen Deckert; Nastaran Behzadnia; Klaus Hartmuth; Reinhard Lührmann
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.